“What is a mere individual to do? Live as sane and decent a life as you can, love your family and friends and understand that everybody is in this together." 

 · Ron Smith

Navigation

Ron Smith Pancreatic Cancer Research Fund

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Ron Smith

December 2, 1941 - December 19, 2011 

A Lasting Legacy for The Voice of Reason

WE'RE GETTING CLOSE TO THE HALF MILLION DOLLAR MARK!

For many years, Ron Smith touched thousands of lives on the WBAL airwaves and in print. He was provocative, provoking, and peerless. The Ron Smith Pancreatic Cancer Research Fund at Johns Hopkins will reinforce Ron’s commitment to transforming the way pancreatic cancer is detected, diagnosed and treated.

“Ron knew death was the intended consequence of life

and he faced it with courage, dignity, and openness.” 

-June Smith    

 

Donations to the Ron Smith Pancreatic Cancer Research Fund at Hopkins will support the work of Dr. Judy Wang, M.D., who, under the direction of Ron's oncologist and cancer research warrior, Dr. Daniel Laheru, is focusiong on early detection of circulating tumor elements in pancreas cancer.

Dr. Wang is evaluating the feasibility and efficacy of detecting quantifiable circulating tumor-associated DNA in the blood, as a marker for presence and burden of the disease.

Ron would have marveled at these remarkable advances and humbled by this lasting legacy in his name. The number of individual lives that will be impacted by your act of generosity reinforces Ron’s commitment to transforming the way pancreatic cancer is detected, diagnosed and treated.

The number of individual lives that will be impacted by your act of generosity reinforces Ron’s commitment to transforming the way pancreatic cancer is detected, diagnosed and treated.

Online donations may be made at kimmelgiving@jhmi.edu or by mail to The Ron Smith Pancreatic Cancer Research Fund, c/o the Sidney Kimmel Comprehensive Cancer Center at Hopkins, 750 East Pratt Street, Suite 1700, Baltimore, MD 21202. Please note “Ron Smith Fund” in the memo section of the check.  

For additional information, please call Dina Mallis Klicos, Director of Major Gifts, at 410 361-6391

All gifts are tax deductible; all donors and the Smith Family will receive an acknowledgement of their gift from Hopkins.

Pancreatic Cancer Update by Daniel Laheru, M.D., Associate Professor of Oncology, Ian T. MacMillian Professorship in Clinical Pancreatic Cancer Research, Johns Hopkins Medicine.

The Statistics

  • 10th leading cause of cancer in the United States (Estimated 43,920 new diagnoses in 2012)
  • 4th leading cause of cancer related death in the United States (Estimated 37,390 deaths)
  • Surgery to remove cancer is the only known cure
  • Only 15-20% of patients at time of diagnosis have surgically removable cancer
  • Of these patients who have surgery, many patients will have their cancer recur, despite surgery and post-surgery chemotherapy or chemotherapy and radiation therapy

The Challenges

  • Lack of understanding  how pancreatic cancer starts, grows and spreads
  • No reliable screening test for pancreatic cancer exists (unlike mammograms for breast cancer, PAP smear for cervical cancer, colonoscopy for colorectal cancer)
  • Only three currently approved chemotherapy drugs
  • Limited research funds are available
  • Few investigators (basic science/clinical research) are devoting careers to pancreatic cancer

Johns Hopkins is leading the way to overcome these challenges

  • We have developed a reliable animal model that faithfully follows how pancreatic cancer first starts, grows and spreads
  • We have a clearer understanding of how pancreatic cancer begins from early cancer changes to a pancreatic cancer
  • We have a better understanding of the genetics of pancreatic cancer. There is a better understanding of how pancreatic cancer spreads, what new gene mutations occur from the original primary tumor to metastases and how pancreatic cancer cells become resistant to chemotherapy
  • The complex relationships between the supporting tumor environment, the immune system and the pancreatic cancer are now better understood.
  • Understanding new identified pathways important in pancreatic cancer growth and spread and how these complicated pathways interact are now better understood.
  • Identify better screening methods to identify early/small cancers before they spread
  • Understanding cancer metabolism and pancreatic cancer
  • New innovative clinical trials testing new treatments based on these new understandings
  • Exposing high school and college summer students, medical students, medical residents, graduate students, post-doctoral basic scientists and clinical fellows to pancreatic cancer research